Most of the TCA enzymes are upregulated during the first metabolic shift in prostate cancer, and then either stay upregulated (CS, FH) or are downregulated (e.g. ACO2, OGDH, and SUCLG1) during the second shift. This evidence concerns the gene OGDH and prostate carcinoma.